BACKGROUND: There is a dearth of data on the longitudinal course and outcome of non-restorative sleep (NRS). METHODS: A total of 2291 middle-aged adults (mean [SD]=46.3 [5.1] years old, 50.0% males at follow-up) were recruited into a 5-year follow-up study. NRS was defined as morning unfreshness after getting up ≥ 3 times/week over the past 12 months. Socio-demographics, other concurrent sleep complaints, and daytime symptoms were measured at baseline. Chronic medical problems in the past one year were additionally assessed at follow up. RESULTS: Several sleep problems (including other insomnia subtypes, snoring, and nightmares) and daytime symptoms were strongly associated with NRS at baseline. NRS had considerable persistence (31.9%), partial remission (22.7%), and incidence rate (5.2%). New incidence of NRS was predicted by female gender (AOR=1.67), preferring not to get up in the morning (AOR=1.96), fatigue (AOR=2.18), and short sleep duration (AOR=1.87), whereas persistence of NRS was predicted by difficulty initiating sleep (AOR=2.36). In the fully adjusted models, baseline NRS was significantly associated with multiple medical disorders at follow-up, including frequent allergic rhinitis (AOR=1.62) and laryngopharyngitis (AOR=2.47), diabetes mellitus (AOR=2.63), gastroesophageal reflux disease (AOR=2.03), eye problems (AOR=2.45), eczema (AOR=2.18), and poor mental health (AOR=1.68). CONCLUSIONS: The persistent course and independent association of NRS with adverse medical and mental outcomes argue for a distinct nosological status and the need for rigorous medical attention.
BACKGROUND: There is a dearth of data on the longitudinal course and outcome of non-restorative sleep (NRS). METHODS: A total of 2291 middle-aged adults (mean [SD]=46.3 [5.1] years old, 50.0% males at follow-up) were recruited into a 5-year follow-up study. NRS was defined as morning unfreshness after getting up ≥ 3 times/week over the past 12 months. Socio-demographics, other concurrent sleep complaints, and daytime symptoms were measured at baseline. Chronic medical problems in the past one year were additionally assessed at follow up. RESULTS: Several sleep problems (including other insomnia subtypes, snoring, and nightmares) and daytime symptoms were strongly associated with NRS at baseline. NRS had considerable persistence (31.9%), partial remission (22.7%), and incidence rate (5.2%). New incidence of NRS was predicted by female gender (AOR=1.67), preferring not to get up in the morning (AOR=1.96), fatigue (AOR=2.18), and short sleep duration (AOR=1.87), whereas persistence of NRS was predicted by difficulty initiating sleep (AOR=2.36). In the fully adjusted models, baseline NRS was significantly associated with multiple medical disorders at follow-up, including frequent allergic rhinitis (AOR=1.62) and laryngopharyngitis (AOR=2.47), diabetes mellitus (AOR=2.63), gastroesophageal reflux disease (AOR=2.03), eye problems (AOR=2.45), eczema (AOR=2.18), and poor mental health (AOR=1.68). CONCLUSIONS: The persistent course and independent association of NRS with adverse medical and mental outcomes argue for a distinct nosological status and the need for rigorous medical attention.
Authors: Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner Journal: J Clin Aesthet Dermatol Date: 2013-07
Authors: Rebecca Robbins; Stuart F Quan; Daniel Buysse; Matthew D Weaver; Matthew P Walker; Christopher L Drake; Kristen Monten; Laura K Barger; Shantha M W Rajaratnam; Thomas Roth; Charles A Czeisler Journal: Front Sleep Date: 2022-07-21
Authors: Sha Li; Daniel Yee Tak Fong; Janet Yuen Ha Wong; Bradley McPherson; Esther Yuet Ying Lau; Lixi Huang; Mary Sau Man Ip Journal: BMC Public Health Date: 2021-04-01 Impact factor: 3.295
Authors: S Li; D Y T Fong; J Y H Wong; K Wilkinson; C Shapiro; E P H Choi; B McPherson; E Y Y Lau; C L K Lam; L X Huang; M S M Ip Journal: Qual Life Res Date: 2020-05-16 Impact factor: 4.147
Authors: Anna Brzecka; Natalia Madetko; Vladimir N Nikolenko; Ghulam M Ashraf; Maria Ejma; Jerzy Leszek; Cyryl Daroszewski; Karolina Sarul; Liudmila M Mikhaleva; Siva G Somasundaram; Cecil E Kirkland; Sergey O Bachurin; Gjumrakch Aliev Journal: Curr Neuropharmacol Date: 2021 Impact factor: 7.363